HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 44.40
-0.10 (-0.22%)
Oct 20, 2026, 1:23 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.31 billion as of October 20, 2026. It is the 27,643rd most valuable company in the world and the 1,570th biggest in Taiwan. Its market cap has decreased by 13.24% in one year.
Market Cap
2.31B
Enterprise Value
1.52B
Revenue
308.21M
Global Rank
Country Rank
#1,570 Taiwan
PE Ratio
17.61
ChartMarket Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.31B, a decrease of -44.34%. That is a compound annual growth rate of -17.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 2.31B | -20.13% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3D Global Biotech | 3.07B |
| Energenesis Biomedical CO.,LTD. | 3.05B |
| Senhwa Biosciences | 2.94B |
| Chunghwa Chemical Synthesis & Biotech | 2.64B |
| GlycoNex Incorporation | 2.44B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.22B |
| Taiwan Bio Therapeutics | 2.21B |
| Syngen Biotech | 2.15B |